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RESUMO
Introdução: A preparação intestinal para colonoscopia e/ou cirurgia coloretal pode induzir alterações hidro-eletrolíticas. O risco destas 
alterações parece estar relacionado com o tipo de preparação intestinal, idade e comorbilidades dos doentes. 
Caso Clínico: Os autores apresentam dois casos de hiponatrémia sintomática (sinais neurológicos focais e coma) após preparação 
intestinal com picossulfato de sódio/citrato de magnésio para colonoscopia. Em ambos os casos, verificou-se resolução completa e 
rápida do quadro clínico depois da correção da hiponatrémia com solução intravenosa de NaCl a 3%. 
Discussão: Os distúrbios eletrolíticos são mais frequentes nas preparações à base de fosfato de sódio e picossulfato de sódio/
citrato de magnésio, nos doentes com mais de 65 anos ou medicados com diuréticos tiazídicos, inibidores da enzima de conversão 
da angiotensina, beta-bloqueantes e antidepressivos e em doentes gastrectomizados. Nestes doentes devemos preferir preparações 
intestinais à base de macrogol (polyethylene glycol).
Conclusão: Em doentes de risco (idade superior a 65 anos, medicados com diuréticos tiazídicos, IECAs, beta-bloqueantes e antide-
pressivos, e antecedentes de gastrectomia) recomendamos soluções à base de macrogol.
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ABSTRACT
Introduction: Bowel preparation for colonoscopy and/or colorectal surgery can cause electrolyte imbalances. The risk of electrolyte 
imbalances seems to be related to the type of bowel cleansing solution, age of patients and comorbidities. 
Case Report: We report two cases of symptomatic hyponatremia (focal neurological signs and coma) after bowel preparation with 
sodium picosulfate/magnesium citrate for colonoscopy. In both cases, symptoms related to hyponatremia rapidly disappeared after 
sodium level correction with intravenous administration of hypertonic saline (3% NaCl). 
Discussion: Electrolyte imbalances are more common with sodium phosphate-based solutions (NaP) and sodium picosulfate/
magnesium citrate, in patients older than 65, in patients treated with thiazide diuretics, angiotensin-converting-enzyme inhibitor, beta-
blockers or antidepressants and in gastrectomized patients. These patients should use macrogol-based solutions (polyethylene glycol). 
Conclusion: In patients at risk (patient > 65 years old, patients taking thiazide diuretics, angiotensin-converting-enzyme inhibitors, 
beta-blockers and antidepressants and with previous gastrectomy) we recommend macrogol-based solutions.
Keywords: Cathartics/adverse effects; Colonoscopy; Hyponatremia
INTRODUCTION
 Bowel preparation for colonoscopy or colorectal surgery 
can cause electrolyte imbalances like hyponatremia which 
may lead to serious consequences such as seizures, loss 
of consciousness, neurological symptoms and eventually 
coma.1 The risk of these electrolyte imbalances seems to 
be related to the type of bowel cleansing solution, age of the 
patient and comorbidities.2
 The authors report two cases of symptomatic 
hyponatremia after bowel preparation for colonoscopy. 
CASE REPORT 
 In both cases the bowel preparation for total colonoscopy 
(for colorectal cancer screening) was done with sodium 
picosulfate/magnesium citrate (MC-SP). 
 The first case refers to a 64-year-old female with previous 
total gastrectomy and depression, taking trazodone and 
diazepam. She was admitted in our Emergency department 
due to sudden coma. She presented with a Glasgow coma 
scale of 5/15. Blood tests showed severe hyponatremia (111 
mmol/L; reference: 136 – 145 mmol/L), hypokalemia (3.3 
mEq/L; reference: 3.5 - 5.0 mEql/L) and decreased serum 
osmolality (240 mOsm/kg; reference: 289 – 308 mOsm/kg). 
 The second case refers to a 69-year-old female with 
hypertension and dyslipidemia treated with losartan, atenolol 
and atorvastatin, who was brought to our Emergency 
department due to sudden dysarthria and paresthesias of her 
upper limbs. Blood tests revealed moderate hyponatremia 
(128 mmol/L) and decreased serum osmolality (248 mOsm/
kg).
 In both cases, there was no history of seizures or 
alcohol consumption, electrocardiogram was normal and 
brain computerized tomography and magnetic resonance 
imaging showed no signs of bleeding or other acute brain 
injuries.
 Patients were considered to have neurological 
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acute hyponatremia. Thus, they were treated with slow 
intravenous infusion of hypertonic saline. Complete 
neurological recovery and normalization of serum sodium 
levels occurred in 48 hours in the first case and in 24 hours 
in the second case.
DISCUSSION
 Bowel cleansing is essential to undergo safe and efficient 
colonoscopy or colorectal surgery.3 Although usually safe it 
may be associated with severe complications.2,4
 The ideal bowel preparation should be easy to drink 
while achieving excellent bowel cleansing and minimizing 
adverse impact over the gastrointestinal tract mucosa 
and electrolyte balance in order to increase the patient’s 
adherence and safety.5
 The most common solutions for colonoscopy pre-
paration include polyethylene glycol (PEG), sodium 
phosphate (NaP) and MC-SP complex.2
 PEG is an inert polymer of ethyleneoxide, formulated 
as a nonabsorbable solution designed to pass through the 
bowel without net absorption nor secretion. Preparations 
containing PEG do not cause histologic damage in the 
gastrointestinal tract mucosa. Thus, PEG is considered 
to be safe for colonic cleansing and complications-free. It 
is recommended to patients with pre-existing electrolyte 
imbalances and in patients who cannot tolerate a significant 
sodium load, namely those with renal failure, congestive 
heart failure or advanced liver disease with ascites.2
 NaP solutions promote an osmotic influx of fluid from the 
intravascular compartment to the bowel lumen. Therefore, 
NaP inevitably carries a possibility of inducing water and 
electrolyte abnormalities.6. Nevertheless, it is a good colon 
cleanser and usually easier to ingest.7
 MC-SP complex acts locally in the colon as a 
combination of a stimulant laxative to increase frequency 
and strength of peristaltsis (sodium picosulfate component) 
and as an osmotic laxative to retain fluid in the colon 
(magnesium citrate component).2 Compared with PEG and 
NaP solutions, it has similar bowel cleaning efficacy but the 
patient’s compliance has been reported to be better than 
with PEG and NaP.8 MC-SP complex and NaP have been 
associated with numerous electrolyte imbalances1  as well 
as colonic mucosa inflammation.2
 Electrolyte imbalances are well-recognized 
complications of bowel preparations and include 
hyponatremia, hypomagnesemia, hypocalcemia and 
hypophosphatemia. Whilst hyponatremia is the most 
frequent one, being reported in up to 7.5% - 8.8% patients, 
it rarely achieves clinical significance.4,9
 Hyponatremia is defined as a serum sodium level less 
than 135 mEq/L. Symptoms do not normally occur unless 
the serum so dium level is lower than 120 mEq/L. However, 
symptoms might occur at a level above that when the 
rate of decrease of the serum sodium level is very abrupt. 
The symptoms range from milder ones, such as loss of 
appetite, nausea, and vomiting, to more severe ones, such 
as seizure, lethargy, coma, and even death. If the patient 
presents with severe neurological symptoms or a serum 
sodium concentra tion less than 110 mEq/L, urgent treat-
ment is required.5
 Bowel preparation-induced coma is uncommon and 
there are only four cases reported in the literature. The age 
of these patients ranged from 64 to 80 years, one patient 
was taking thiazide diuretics and beta blockers, another 
patient had a previous history of gastrectomy, two patients 
used NaP solutions and two other patients used MC-SP 
complex.5,6,9
 Because of the osmotic activity of the chemical contents 
of the NaP and MC-SP complex, these solutions induce 
water and electrolyte abnormalities.10 For this reason, 
elderly individuals and patients with impaired renal function, 
liver cirrhosis or congestive heart failure are more prone to 
these events.6
 Studies that investigated the risk of hyponatremia in 
elderly patients taking PEG and MC-SP, showed that the 
incidence of hyponatremia was higher in patients taking 
MC-SP, even though there were no significant differences 
in terms of neurological symptoms or length of hospital 
stay.11 In order to prevent hyponatremia, patients should 
be instructed to take MC-SP with a generous amount of 
water. In addition, care should be taken when using MC-
SP complex in patients with impaired renal function, heart 
failure, inflammatory bowel disease12 and patients taking 
drugs for hypertension and depression.13
 Gastrectomy is also considered a risk factor for 
hyponatremia related to bowel preparation. The rapid 
emptying of bowel preparation solutions into the small 
intestine with the addition of accelerated bowel movements 
may result in an exaggerated intravascular volume 
contraction and hence in acute hypovolemic hyponatremia.6 
Furthermore, in states of hypovolemia there is a stimulation 
of water retention through arginine vasopressin (AVP) 
stimulation of aquaporin (AQP) expression in the renal 
principal cell, worsening hyponatremia (dilution).14
 Until now, there is no evidence that ‘split-dose’ regimens 
avoid or decrease electrolyte imbalances; the advantage 
of these regimens is the better tolerability with equal 
effectiveness when compared to standard regimes.15
 Bowel preparation-induced hyponatremia should be 
treated with slow intravenous infusion of hypertonic saline 
aiming to increase sodium level at a rate of 0.5 mmol/L/h, 
not exceeding 12 mmol/L in the first 24 hours nor 18 mmol/L 
in the first 48 hours to avoid osmotic demyelination and 
brain edema. Usually, it takes 48h - 72h for full clinical and 
sodium balance recovery.16
 Our report calls the attention to the importance of the 
patient´s medical history when choosing a bowel pre-
paration solution. Moreover, in patients presenting with 
neurological symptoms while taking these solutions, we 
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CONCLUSION
 Hyponatremia may be a complication of bowel cleansing. 
It is usually asymptomatic but sometimes may lead to 
serious although reversible manifestations such as coma. 
The risk of hyponatremia appears to be related not only to 
age and comorbidities but also to the type of product used 
to clean the bowel. This risk is higher with NaP-based and 
MC-SP complex preparations. Therefore, in patients at risk 
(patient > 65 years old, patients taking thiazide diuretics, 
ACE inhibitors, beta-blockers and antidepressants and with 
previous gastrectomy) we recommend macrogol-based 
solutions. 
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